Marcel P. Devetten

Nebraska Medical Center — United States

Medicine · Health Sciences

20h-index2.0kcitations71works0.02yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Hematopoietic Stem Cell Transplantation(25), Chronic Lymphocytic Leukemia Research(16), Acute Myeloid Leukemia Research(15), Chronic Myeloid Leukemia Treatments(11), Mesenchymal stem cell research(8)

Publications67 total

Antiretroviral medication prescribing errors are common with hospitalization of HIV-infected patients
Journal of Antimicrobial Chemotherapy·2013· 29 citedOpen Access
Leukemic Relapse Following MMSC Rescue in a Murine Model of GVHD
The FASEB Journal·2013
Association Between Hyperglycemia and Hospital Length of Stay in Patients Undergoing Hematopoietic Stem Cell Transplantation
The Endocrinologist·2010· 4 cited
Firstline treatment of patients with chronicphase chronic myelogenous leukemia: progress and remaining questions
Community Oncology·2010
Single Cycle of Arsenic Trioxide–Based Consolidation Chemotherapy Spares Anthracycline Exposure in the Primary Management of Acute Promyelocytic Leukemia
Journal of Clinical Oncology·2010· 88 citedOpen Access
Immune Responses in AML Patients Following Vaccination with GRNVAC1, Autologous RNA Transfected Dendritic Cells Expressing Telomerase Catalytic Subunit hTERT.
Blood·2009· 17 cited
AC220, a Potent, Selective, Second Generation FLT3 Receptor Tyrosine Kinase (RTK) Inhibitor, in a First-in-Human (FIH) Phase 1 AML Study.
Blood·2009· 66 cited
Chronic Myelogenous Leukemia
Journal of the National Comprehensive Cancer Network·2009· 209 citedOpen Access
Adult Human Mesenchymal Stem Cells Added to Corticosteroid Therapy for the Treatment of Acute Graft-versus-Host Disease
Biology of Blood and Marrow Transplantation·2009· 431 citedOpen Access
Randomized phase II trial of the nucleolin targeting aptamer AS1411 combined with high-dose cytarabine in relapsed/refractory acute myeloid leukemia (AML)
Journal of Clinical Oncology·2009· 44 cited
Evaluation of mycophenolate mofetil for initial treatment of chronic graft-versus-host disease
Blood·2009· 158 citedOpen Access
Hyperglycemia in Allogeneic Hematopoietic Stem Cell Transplant (alloHSCT)Patients: Prevalance and Impact on Outcomes
Biology of Blood and Marrow Transplantation·2009Open Access
Chronic Myelogenous LeukemiaPractice Guidelines in Oncology TM
2009
Unrelated Donor Reduced-Intensity Allogeneic Hematopoietic Stem Cell Transplantation for Relapsed and Refractory Hodgkin Lymphoma
Biology of Blood and Marrow Transplantation·2009· 104 citedOpen Access
Phase 1 AML Study of AC220, a Potent and Selective Second Generation FLT3 Receptor Tyrosine Kinase Inhibitor
Blood·2008· 12 cited
Effectiveness of Peripheral Blood (PB) Molecular Monitoring by Quantitative RT-PCR (Q-PCR) in Phase II Acute Promyelocytic Leukemia (APL) Trial J0422.
Blood·2008· 1 cited
Minimizing Therapy for Patients with Acute Promyelocytic Leukemia: Efficacy of Single Cycle of Arsenic-Based Consolidation Therapy.
Blood·2008
Refractory CML: Not all forms of resistance are equal
2008
49: Rural-Urban Disparities in Survival Outcome After Hematopoietic Stem Cell Transplantation for Hematologic Malignancies
Biology of Blood and Marrow Transplantation·2008
331: Effect of Smoking on Mobilization of Hematopoietic Stem Cells in Healthy Donors
Biology of Blood and Marrow Transplantation·2008· 1 citedOpen Access
page 1 of 4Next →

Frequent Co-authors

Julie M. Vose(11), Fausto R. Loberiza(9), Jamés O. Armitage(8), Philip J. Bierman(8), R. Gregory Bociek(6), Lori J. Maness(6), Scott D. Rowley(5), James M. Foran(5), Mikkael A. Sekeres(4), Solveig G. Ericson(4), Apar Kishor Ganti(4), Erkut Bahceci(3), Joseph P. McGuirk(3), Joseph P. Uberti(3), Steven M. Devine(3), Harry P. Erba(3), Madan Jagasia(3), Martin S. Tallman(3), Stephanie J. Lee(3), Koen van Besien(3)